Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.

West NR, Lindberg MF, Dairou J, MacGregor S, Puthireddy S, Meijer L, Bhattacharyya A

Open source

DOI
10.1242/dmm.052740
Published
2026 Jun 1
Container
Disease models & mechanisms
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1242/dmm.052740,
  title = {Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.},
  author = {West NR and Lindberg MF and Dairou J and MacGregor S and Puthireddy S and Meijer L and Bhattacharyya A},
  year = {2026},
  journal = {Disease models \& mechanisms},
  doi = {10.1242/dmm.052740},
  url = {https://doi.org/10.1242/dmm.052740}
}

RIS

TY  - JOUR
TI  - Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.
AU  - West NR
AU  - Lindberg MF
AU  - Dairou J
AU  - MacGregor S
AU  - Puthireddy S
AU  - Meijer L
AU  - Bhattacharyya A
PY  - 2026
JO  - Disease models & mechanisms
DO  - 10.1242/dmm.052740
UR  - https://doi.org/10.1242/dmm.052740
ER  - 

APA

NR, W., MF, L., J, D., S, M., S, P., L, M., & A, B. (2026). Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.. Disease models & mechanisms. https://doi.org/10.1242/dmm.052740

Source records